Trademark Information
Application ID
Status
Date of Application
22 February 2023
Classes
5
Proprietor
Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Sarkhej – Gandhinagar Highway, Ahmedabad – 382481
Attorney
Sagar Chandra & Associates[5676]
S 227, Panchshila Park, New Delhi 110017
Type
Device
State
Gujarat
Country
Filing Mode
e-Filing
IP Office
AHMEDABAD
Used Since
09 February 2018
Valid / Upto
Description
[Class : 5] Glucose Dietary Supplements, Glucose For Medical Purposes, Dietetic Foods, Nutritional Supplements Adapted For Medicinal Purposes, Dietary Supplements For Humans; Nutritional Supplements.
Image (DEVICE)
Uploaded Documents
| 1 | TM-A(TRADE MARKS APPLICATION) | 22 Feb 2023 |
| 2 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 09 May 2023 |
| 3 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 10 May 2023 |
| 4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 10 May 2023 |
| 5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 23 Jun 2023 |
| 6 | Reply to Exam Report (MIS-R) | 29 Oct 2023 |
| 7 | Journal Copy | 15 Dec 2023 |
| 8 | TM-O(NOTICE OF OPPOSITION) | 21 Mar 2024 |
| 9 | Annexure -1 under rule 46 | 19 Oct 2024 |
| 9 | Evidence Affidavit Under Rule 46 (TOP) | 19 Oct 2024 |
| 10 | Annexure -1 under rule 46 | 19 Oct 2024 |
| 11 | Evidence Affidavit Under Rule 46 (TOP) | 19 Oct 2024 |
| 12 | Annexure -1 under rule 46 | 19 Oct 2024 |
| 12 | Evidence Affidavit Under Rule 46 (TOP) | 19 Oct 2024 |
| 13 | Evidence Affidavit Under Rule 46 (TOP) | 19 Oct 2024 |
| 14 | Annexure -1 under rule 46 | 19 Oct 2024 |
| 15 | Annexure -1 under rule 46 | 19 Oct 2024 |
| 15 | Evidence Affidavit Under Rule 46 (TOP) | 19 Oct 2024 |
| 16 | Annexure -1 under rule 46 | 19 Oct 2024 |
| 16 | Evidence Affidavit Under Rule 46 (TOP) | 19 Oct 2024 |
Correspondence and Notices
| 1 | EXAMINATION REPORT | 16147566 | 29 Sep 2023 | |
| 2 | Opposition Notice | 18189944 | 6733005 | 20 May 2024 |
| 3 | Opposition Counter Statement | 18286018 | 6755326 | 10 Jun 2024 |
Sign In to view All Documents & Correspondence